Literature DB >> 28233767

Tumor size, tumor location, and antitumor inflammatory response are associated with lymph node size in colorectal cancer patients.

Ortrun Rössler1,2, Johannes Betge3, Lars Harbaum4, Karl Mrak5,6, Jörg Tschmelitsch5, Cord Langner1.   

Abstract

Lymph node size affects lymph node retrieval in surgical specimen and is used as criterion for pre-operative radiological estimation of metastatic disease. However, factors determining lymph node size remain to be established. Therefore, the association between lymph node size and presence of metastatic cancer deposits as well as different primary tumor characteristics was analyzed in a prospective cross-sectional study. Visible and palpable nodes were harvested, and conventional histology, immunohistochemistry, and molecular analysis were performed. The study cohort comprised 148 patients (median age 69 years, range 36-92). Lymph node dissection rendered 4167 nodes. Mean lymph node count was 28 (median 26, range 9-67). Metastatic disease was detected in 320 (8%) nodes and was associated with lymph node size (P<0.001). Positive nodes measuring ≤2 mm caused upstaging within the N category in one third of cases, but did not identify patients as node-positive as all patients also had positive larger nodes. Large tumor size (P=0.001), right tumor location (P<0.001), and deep tumor penetration (P=0.024) were all independently associated with lymph node size, whereas high lymphocytic antitumor reaction just missed statistical significance (P=0.053) in multivariable analysis. Microsatellite instability had no influence on lymph node size when analysis was restricted to right-sided tumors. In conclusion, analysis of small lymph nodes may lead to upstaging within the N category, but they do not identify a patient as node-positive and do therefore not influence clinical decision-making in the adjuvant setting. The majority of enlarged lymph nodes, including those measuring >1 cm, are not involved by cancer. Different tumor characteristics, such as large primary tumor size, right tumor location, and deep tumor penetration are independently associated with lymph node size and need to be considered when interpreting enlarged nodes detected by radiological imaging.

Entities:  

Mesh:

Year:  2017        PMID: 28233767     DOI: 10.1038/modpathol.2016.227

Source DB:  PubMed          Journal:  Mod Pathol        ISSN: 0893-3952            Impact factor:   7.842


  30 in total

1.  The clinical significance of lymph node size in colon cancer.

Authors:  Bruno Märkl; Janine Rößle; Hans M Arnholdt; Tina Schaller; Ines Krammer; Claudio Cacchi; Hendrik Jähnig; Gerhard Schenkirsch; Hanno Spatz; Matthias Anthuber
Journal:  Mod Pathol       Date:  2012-06-08       Impact factor: 7.842

2.  Rectal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.

Authors:  B Glimelius; L Påhlman; A Cervantes
Journal:  Ann Oncol       Date:  2010-05       Impact factor: 32.976

3.  Lymph node size as a predictor of lymphatic staging in colonic cancer.

Authors:  D A M Sloothaak; S Grewal; H Doornewaard; P van Duijvendijk; P J Tanis; W A Bemelman; E S van der Zaag; C J Buskens
Journal:  Br J Surg       Date:  2014-03-26       Impact factor: 6.939

4.  Number of nodes examined and staging accuracy in colorectal carcinoma.

Authors:  J H Wong; R Severino; M B Honnebier; P Tom; T S Namiki
Journal:  J Clin Oncol       Date:  1999-09       Impact factor: 44.544

5.  Tumour 'budding' as an index to estimate the potential of aggressiveness in rectal cancer.

Authors:  H Ueno; J Murphy; J R Jass; H Mochizuki; I C Talbot
Journal:  Histopathology       Date:  2002-02       Impact factor: 5.087

Review 6.  Colorectal cancer and lymph nodes: the obsession with the number 12.

Authors:  Giovanni Li Destri; Isidoro Di Carlo; Roberto Scilletta; Beniamino Scilletta; Stefano Puleo
Journal:  World J Gastroenterol       Date:  2014-02-28       Impact factor: 5.742

7.  Methylene blue injection into the rectal artery as a simple method to improve lymph node harvest in rectal cancer.

Authors:  Bruno Märkl; Therese G Kerwel; Theodor Wagner; Matthias Anthuber; Hans M Arnholdt
Journal:  Mod Pathol       Date:  2007-05-04       Impact factor: 7.842

8.  Lymphocytic reaction to colorectal cancer is associated with longer survival, independent of lymph node count, microsatellite instability, and CpG island methylator phenotype.

Authors:  Shuji Ogino; Katsuhiko Nosho; Natsumi Irahara; Jeffrey A Meyerhardt; Yoshifumi Baba; Kaori Shima; Jonathan N Glickman; Cristina R Ferrone; Mari Mino-Kenudson; Noriko Tanaka; Glenn Dranoff; Edward L Giovannucci; Charles S Fuchs
Journal:  Clin Cancer Res       Date:  2009-10-13       Impact factor: 12.531

Review 9.  Colorectal carcinoma: selected issues in pathologic examination and staging and determination of prognostic factors.

Authors:  Mary Kay Washington
Journal:  Arch Pathol Lab Med       Date:  2008-10       Impact factor: 5.534

Review 10.  Lymph node staging in colorectal cancer: old controversies and recent advances.

Authors:  Annika Resch; Cord Langner
Journal:  World J Gastroenterol       Date:  2013-12-14       Impact factor: 5.742

View more
  12 in total

1.  The association between microsatellite instability and lymph node count in colorectal cancer.

Authors:  Alexander Arnold; Matthias Kloor; Lina Jansen; Jenny Chang-Claude; Hermann Brenner; Moritz von Winterfeld; Michael Hoffmeister; Hendrik Bläker
Journal:  Virchows Arch       Date:  2017-05-23       Impact factor: 4.064

Review 2.  Diagnostic and therapeutic biomarkers in colorectal cancer: a review.

Authors:  Jéssica Vieira de Assis; Lucélia Antunes Coutinho; Ifeoluwa Temitayo Oyeyemi; Oyetunde Timothy Oyeyemi; Rafaella Fortini E Queiroz Grenfell
Journal:  Am J Cancer Res       Date:  2022-02-15       Impact factor: 6.166

3.  Can factors that influence nodal dissemination in patients with colorectal cancer be identified? Own experience.

Authors:  Konrad P Zaręba; Justyna Zińczuk; Tomasz Dawidziuk; Mariusz Rosołowski; Anna Pryczynicz; Katarzyna Guzińska-Ustymowicz; Bogusław Kędra
Journal:  Prz Gastroenterol       Date:  2020-09-19

4.  The prognostic significance of lymph node size in node-positive colon cancer.

Authors:  Philipp Schrembs; Benedikt Martin; Matthias Anthuber; Gerhard Schenkirsch; Bruno Märkl
Journal:  PLoS One       Date:  2018-08-10       Impact factor: 3.240

5.  Development and external validation of a predictive scoring system associated with metastasis of T1-2 colorectal tumors to lymph nodes.

Authors:  Shaobo Mo; Zheng Zhou; Weixing Dai; Wenqiang Xiang; Lingyu Han; Long Zhang; Renjie Wang; Sanjun Cai; Qingguo Li; Guoxiang Cai
Journal:  Clin Transl Med       Date:  2020-01

6.  Prediction of Colon Cancer Stages and Survival Period with Machine Learning Approach.

Authors:  Pushpanjali Gupta; Sum-Fu Chiang; Prasan Kumar Sahoo; Suvendu Kumar Mohapatra; Jeng-Fu You; Djeane Debora Onthoni; Hsin-Yuan Hung; Jy-Ming Chiang; Yenlin Huang; Wen-Sy Tsai
Journal:  Cancers (Basel)       Date:  2019-12-12       Impact factor: 6.639

7.  Hemicolectomy Does Not Provide Survival Benefit for Right-Sided Mucinous Colon Adenocarcinoma.

Authors:  Jia Huang; Qiulin Huang; Rong Tang; Guodong Chen; Yiwei Zhang; Rongfang He; Xuyu Zu; Kai Fu; Xiuda Peng; Shuai Xiao
Journal:  Front Oncol       Date:  2021-02-01       Impact factor: 6.244

8.  A greater lymph node yield is required during pathological examination in microsatellite instability-high gastric cancer.

Authors:  Zhenghao Cai; Haiqin Song; Abe Fingerhut; Jing Sun; Junjun Ma; Luyang Zhang; Shuchun Li; Chaoran Yu; Minhua Zheng; Lu Zang
Journal:  BMC Cancer       Date:  2021-03-25       Impact factor: 4.430

9.  Microsatellite Status Affects Tumor Response and Survival in Patients Undergoing Neoadjuvant Chemotherapy for Clinical Stage III Gastric Cancer.

Authors:  Zhenghao Cai; Weiwei Rui; Shuchun Li; Abraham Fingerhut; Jing Sun; Junjun Ma; Lu Zang; Zhenggang Zhu; Minhua Zheng
Journal:  Front Oncol       Date:  2020-12-15       Impact factor: 6.244

10.  Rectal cancer: a methodological approach to matching PET/MRI to histopathology.

Authors:  Miriam K Rutegård; Malin Båtsman; Lennart Blomqvist; Martin Rutegård; Jan Axelsson; Ingrid Ljuslinder; Jörgen Rutegård; Richard Palmqvist; Fredrik Brännström; Patrik Brynolfsson; Katrine Riklund
Journal:  Cancer Imaging       Date:  2020-10-31       Impact factor: 3.909

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.